PT575054E - Derivados de proteina c - Google Patents
Derivados de proteina cInfo
- Publication number
- PT575054E PT575054E PT93303894T PT93303894T PT575054E PT 575054 E PT575054 E PT 575054E PT 93303894 T PT93303894 T PT 93303894T PT 93303894 T PT93303894 T PT 93303894T PT 575054 E PT575054 E PT 575054E
- Authority
- PT
- Portugal
- Prior art keywords
- derivatives
- human protein
- protein derivatives
- producing
- high activity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6464—Protein C (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88719192A | 1992-05-21 | 1992-05-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT575054E true PT575054E (pt) | 2005-03-31 |
Family
ID=25390640
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT93303894T PT575054E (pt) | 1992-05-21 | 1993-05-19 | Derivados de proteina c |
Country Status (23)
Country | Link |
---|---|
US (1) | US5453373A (pt) |
EP (1) | EP0575054B1 (pt) |
JP (1) | JP3564150B2 (pt) |
KR (1) | KR100291529B1 (pt) |
CN (1) | CN1080658A (pt) |
AT (1) | ATE286121T1 (pt) |
AU (1) | AU661901B2 (pt) |
BR (1) | BR9301944A (pt) |
CA (1) | CA2096604C (pt) |
CZ (1) | CZ286016B6 (pt) |
DE (1) | DE69333727T2 (pt) |
DK (1) | DK0575054T3 (pt) |
ES (1) | ES2233925T3 (pt) |
FI (1) | FI932282A (pt) |
HU (1) | HU218408B (pt) |
IL (1) | IL105757A0 (pt) |
MX (1) | MX9302917A (pt) |
MY (1) | MY110664A (pt) |
NO (1) | NO311299B1 (pt) |
NZ (1) | NZ247651A (pt) |
PH (1) | PH29911A (pt) |
PT (1) | PT575054E (pt) |
RU (1) | RU2122004C1 (pt) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2067525C (en) * | 1991-05-09 | 1998-09-15 | Helmut G. Alt | Organometallic fluorenyl compounds, preparation and use |
AT402262B (de) * | 1991-06-20 | 1997-03-25 | Immuno Ag | Arzneimittel enthaltend aktiviertes protein c |
US5716795A (en) * | 1991-10-04 | 1998-02-10 | Matschiner; John T. | Thrombomodulin-based coagulometric assay of the protein C system |
AU2870992A (en) * | 1991-10-04 | 1993-05-03 | Board Of Regents Of The University Of Nebraska, The | A soluble thrombomodulin-based one-stage assay for vitamin k-dependent coagulation-inhibiting proteins |
DE4320294A1 (de) * | 1993-06-18 | 1994-12-22 | Immuno Ag | Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen |
US6630137B1 (en) | 1997-04-28 | 2003-10-07 | Eli Lilly And Company | Activated protein C formulations |
HU224826B1 (en) | 1997-04-28 | 2006-02-28 | Lilly Co Eli | Activated protein c formulations |
ZA984698B (en) * | 1997-06-05 | 2000-02-01 | Lilly Co Eli | Methods for treating thombotic disorders. |
HUP0001237A3 (en) * | 1997-10-20 | 2002-01-28 | Lilly Co Eli | Methods for treating vascular disorders |
JP2003506006A (ja) * | 1998-07-31 | 2003-02-18 | イーライ・リリー・アンド・カンパニー | 活性化プロテインcの寒冷顆粒化 |
US6815533B1 (en) | 1998-07-31 | 2004-11-09 | Eli Lilly And Company | Cryogranulation of activated protein C |
CN1324244A (zh) | 1998-10-22 | 2001-11-28 | 伊莱利利公司 | 治疗脓毒症的方法 |
CA2351067A1 (en) | 1998-11-13 | 2000-05-25 | Eli Lilly And Company | Method of treating heparin-induced thrombocytopenia |
ES2195655T3 (es) | 1998-11-20 | 2003-12-01 | Lilly Co Eli | Procedimiento para tratar fiebre hemorragica virica con proteina c. |
BR9915572A (pt) | 1998-11-23 | 2001-08-14 | Lilly Co Eli | Processo de tratamento de doença de célula falciforme e talassemia |
US6998122B1 (en) * | 1999-04-30 | 2006-02-14 | Eli Lilly And Company | Protein C derivatives |
JP2003514545A (ja) * | 1999-11-19 | 2003-04-22 | イーライ・リリー・アンド・カンパニー | プロテインc誘導体 |
ES2234807T3 (es) * | 2000-02-02 | 2005-07-01 | Eli Lilly And Company | Derivados de proteina c. |
EP1263943A1 (en) * | 2000-02-11 | 2002-12-11 | Eli Lilly & Company | Protein c derivatives |
US7204981B2 (en) * | 2000-03-28 | 2007-04-17 | Eli Lilly And Company | Methods of treating diseases with activated protein C |
US6933367B2 (en) | 2000-10-18 | 2005-08-23 | Maxygen Aps | Protein C or activated protein C-like molecules |
KR20030060915A (ko) * | 2000-10-18 | 2003-07-16 | 맥시겐 에이피에스 | 단백질 씨 또는 활성 단백질 씨-유사 분자 |
IL154999A0 (en) * | 2000-10-18 | 2003-10-31 | Maxygen Aps | Protein c or activated protein c-like molecules |
US20040198652A1 (en) * | 2001-04-24 | 2004-10-07 | Carter J. Paul | Methods and compositions for preventing and treating septic shock and endotoxemia |
AU2003213146A1 (en) * | 2002-03-08 | 2003-09-22 | Eli Lilly And Company | Activated protein c formulations |
WO2003106666A2 (en) * | 2002-06-14 | 2003-12-24 | Maxygen Aps | Protein c variants with altered properties |
US20070142272A1 (en) * | 2003-01-24 | 2007-06-21 | Zlokovic Berislav V | Neuroprotective activity of activated protein c independent of its anticoagulant activity |
WO2006014839A2 (en) * | 2004-07-23 | 2006-02-09 | The University Of Rochester | Activated protein c inhibits undesirable effects of plasminogen activator in the brain |
EP1913155A4 (en) * | 2005-06-23 | 2009-08-12 | Univ British Columbia | COAGULATION FACTOR III POLYMORPHISMS ASSOCIATED WITH PREDICTION RELATING TO THE RESULTS AND RESPONSE OF A SUBJECT TO THERAPY |
EP2041338A4 (en) * | 2006-06-09 | 2009-09-30 | Univ British Columbia | INTERFERON GAMMA POLYMORPHISMS AS INDICATORS OF PATIENT RESULTS IN FATIGUE PATIENTS |
EP2178556B1 (en) * | 2007-06-18 | 2011-08-17 | Oregon Health & Science University | Protein c for use in maintaining hemostasis |
US20110171200A1 (en) * | 2008-01-15 | 2011-07-14 | Walley Keith R | Protein c rs2069915 as a response predictor to survival and administration of activated protein c or protein c-like compound |
CN104262479A (zh) | 2008-12-19 | 2015-01-07 | 国家健康与医学研究院 | 丝氨酸蛋白酶衍生物及其在凝血功能障碍的预防或治疗中的用途 |
WO2012068519A2 (en) | 2010-11-19 | 2012-05-24 | Sirius Genomics Inc. | Markers associated with response to activated protein c administration, and uses thereof |
US20150150954A1 (en) | 2012-07-04 | 2015-06-04 | The University Of Sydney | Treatment of inflammatory skin disorders |
DK3137102T3 (da) | 2014-04-16 | 2021-10-11 | Zz Biotech Llc | Apc til anvendelse til behandling af unormal kutan ardannelse |
WO2023119230A1 (en) | 2021-12-22 | 2023-06-29 | L'oreal | Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4775624A (en) * | 1985-02-08 | 1988-10-04 | Eli Lilly And Company | Vectors and compounds for expression of human protein C |
US4992373A (en) * | 1987-12-04 | 1991-02-12 | Eli Lilly And Company | Vectors and compounds for direct expression of activated human protein C |
ZA889497B (en) * | 1987-12-28 | 1990-08-29 | Lilly Co Eli | Vectors and compounds for expression of zymogen forms of human protein c |
US4981952A (en) * | 1988-10-04 | 1991-01-01 | Eli Lilly And Company | Method for the purification of vitamin K-dependent proteins |
US5270178A (en) * | 1990-02-23 | 1993-12-14 | Eli Lilly And Company | Vectors and compounds for expression of zymogen forms of human protein C |
IL97311A0 (en) * | 1990-02-23 | 1992-05-25 | Lilly Co Eli | Vectors and compounds for expression of glycosylation mutants of human protein c |
-
1993
- 1993-05-18 MY MYPI93000913A patent/MY110664A/en unknown
- 1993-05-19 AT AT93303894T patent/ATE286121T1/de not_active IP Right Cessation
- 1993-05-19 PT PT93303894T patent/PT575054E/pt unknown
- 1993-05-19 EP EP93303894A patent/EP0575054B1/en not_active Expired - Lifetime
- 1993-05-19 DK DK93303894T patent/DK0575054T3/da active
- 1993-05-19 CZ CZ93948A patent/CZ286016B6/cs not_active IP Right Cessation
- 1993-05-19 DE DE69333727T patent/DE69333727T2/de not_active Expired - Fee Related
- 1993-05-19 NZ NZ247651A patent/NZ247651A/en unknown
- 1993-05-19 KR KR1019930008613A patent/KR100291529B1/ko not_active IP Right Cessation
- 1993-05-19 NO NO19931840A patent/NO311299B1/no not_active IP Right Cessation
- 1993-05-19 FI FI932282A patent/FI932282A/fi unknown
- 1993-05-19 CA CA002096604A patent/CA2096604C/en not_active Expired - Fee Related
- 1993-05-19 HU HU9301461A patent/HU218408B/hu not_active IP Right Cessation
- 1993-05-19 ES ES93303894T patent/ES2233925T3/es not_active Expired - Lifetime
- 1993-05-19 RU RU93005089A patent/RU2122004C1/ru active
- 1993-05-19 MX MX9302917A patent/MX9302917A/es unknown
- 1993-05-20 PH PH46212A patent/PH29911A/en unknown
- 1993-05-20 CN CN93106214A patent/CN1080658A/zh active Pending
- 1993-05-20 IL IL105757A patent/IL105757A0/xx unknown
- 1993-05-20 JP JP11822393A patent/JP3564150B2/ja not_active Expired - Fee Related
- 1993-05-20 AU AU38699/93A patent/AU661901B2/en not_active Ceased
- 1993-05-20 BR BR9301944A patent/BR9301944A/pt not_active Application Discontinuation
- 1993-07-09 US US08/089,215 patent/US5453373A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU3869993A (en) | 1993-11-25 |
CZ286016B6 (cs) | 1999-12-15 |
NZ247651A (en) | 1995-03-28 |
PH29911A (en) | 1996-09-16 |
CN1080658A (zh) | 1994-01-12 |
MX9302917A (es) | 1993-11-01 |
DK0575054T3 (da) | 2005-04-25 |
JPH0680698A (ja) | 1994-03-22 |
KR930023370A (ko) | 1993-12-18 |
RU2122004C1 (ru) | 1998-11-20 |
NO931840D0 (no) | 1993-05-19 |
NO311299B1 (no) | 2001-11-12 |
EP0575054A3 (en) | 1995-04-19 |
FI932282A0 (fi) | 1993-05-19 |
ATE286121T1 (de) | 2005-01-15 |
MY110664A (en) | 1999-01-30 |
CZ94893A3 (en) | 1994-01-19 |
NO931840L (no) | 1993-11-22 |
EP0575054B1 (en) | 2004-12-29 |
US5453373A (en) | 1995-09-26 |
DE69333727D1 (de) | 2005-02-03 |
EP0575054A2 (en) | 1993-12-22 |
CA2096604A1 (en) | 1993-11-22 |
HU218408B (hu) | 2000-08-28 |
ES2233925T3 (es) | 2005-06-16 |
DE69333727T2 (de) | 2005-12-15 |
HUT69615A (en) | 1995-09-28 |
HU9301461D0 (en) | 1993-09-28 |
KR100291529B1 (ko) | 2001-06-01 |
CA2096604C (en) | 2003-12-16 |
BR9301944A (pt) | 1993-11-30 |
AU661901B2 (en) | 1995-08-10 |
JP3564150B2 (ja) | 2004-09-08 |
FI932282A (fi) | 1993-11-22 |
IL105757A0 (en) | 1993-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT575054E (pt) | Derivados de proteina c | |
NO900770L (no) | Produksjon av glykoseoksidase i rekombinante systemer. | |
DE69514342T2 (de) | Modifizierte polypeptide mit erhoehter biologischer aktivitaet | |
ES2087056T3 (es) | 2-pirimidinaminas sustituidas en las posiciones 4, 5 y 6. | |
YU31891A (sh) | Vektori i jedinjenja za ekspresiju mutanata glikozilovanja humanog proteina c | |
DE69033756T2 (de) | Gene, die für MACIF Proteine kodieren, Expressionsvektoren mit diesem Genen, und Transformantenzellen mit diesem Proteinen | |
DE3882611T2 (de) | Menschliches Interleukin-4, Expressionsvektoren dafür und diese enthaltende Transformanten. | |
MX9202871A (es) | 5-(amino substituidas)-8-(fenil substituidas)-3h,6h-1,4,5a,8a-tetraazaacenaf-tilen-3-onas. | |
DE68924022T2 (de) | Protein mit hemmender Aktivität gegenüber menschlichem Plasmin. | |
DE29614891U1 (de) | Stützelement | |
DE3862073D1 (de) | Tetramethyl-cis-diaza-bicyclo(4.2.0.)oktan-3,5-dion-derivate mit differentiationsinduzierender aktivitaet. | |
ITRM930343A0 (it) | Proteine ricombinanti, vettori per l'espressione e loro usi. | |
MX9203129A (es) | Proteinas bmp-5. | |
FI950779A (fi) | Homepromoottorit, jotka ovat aktiivisia glukoosin läsnäollessa |